Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -90.44% is in line with its 5-year average of -96.06%, around the middle of its 5-year range (-211.99%–-27.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 48.99% above its 12-month average of -177.31%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -90.44%.
RETURN ON EQUITY (ROE)
-90.44%
RETURN ON EQUITY (ROE) AVG TTM
-177.31%
RETURN ON EQUITY (ROE) AVG 3Y
-128.85%
RETURN ON EQUITY (ROE) AVG 5Y
-96.06%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+48.99%
CURRENT VS 3Y AVG
+29.81%
CURRENT VS 5Y AVG
+5.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-115.29%
vs the sector median at left
INmune Bio, Inc.
Market Cap
$48.65M
Return on Equity (ROE)
-90.44%
TTM Avg
-177.31%
3Y Avg
-128.85%
5Y Avg
-96.06%
Market Cap
$48.99M
Return on Equity (ROE)
N/A
TTM Avg
-374.04%
3Y Avg
-326.22%
5Y Avg
-254.86%
Market Cap
$48.53M
Return on Equity (ROE)
-23.70%
TTM Avg
-170.56%
3Y Avg
-190.10%
5Y Avg
-146.13%
Market Cap
$47.90M
Return on Equity (ROE)
-42.01%
TTM Avg
-2.07%
3Y Avg
11.82%
5Y Avg
5.22%
Market Cap
$49.35M
Return on Equity (ROE)
N/A
TTM Avg
-382.07%
3Y Avg
-282.25%
5Y Avg
-171.00%
Market Cap
$49.47M
Return on Equity (ROE)
-17.84%
TTM Avg
-32.49%
3Y Avg
-23.88%
5Y Avg
-18.14%
Market Cap
$47.47M
Return on Equity (ROE)
-170.94%
TTM Avg
-132.56%
3Y Avg
-85.15%
5Y Avg
-88.00%
Market Cap
$47.27M
Return on Equity (ROE)
-28.20%
TTM Avg
-53.22%
3Y Avg
-59.23%
5Y Avg
-46.35%
Market Cap
$50.65M
Return on Equity (ROE)
-57.10%
TTM Avg
-36.66%
3Y Avg
-227.16%
5Y Avg
-314.45%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $48.65M | -90.44% | -177.31% | -128.85% | -96.06% |
| TELA Bio, Inc. (TELA)vs › | $48.99M | N/A | -374.04% | -326.22% | -254.86% |
| Microbot Medical Inc. (MBOT)vs › | $48.53M | -23.70% | -170.56% | -190.10% | -146.13% |
| Sensus Healthcare, Inc. (SRTS)vs › | $47.90M | -42.01% | -2.07% | 11.82% | 5.22% |
| Apollomics, Inc. (APLM)vs › | $49.35M | N/A | -382.07% | -282.25% | -171.00% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.47M | -17.84% | -32.49% | -23.88% | -18.14% |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | -170.94% | -132.56% | -85.15% | -88.00% |
| Instil Bio, Inc. (TIL)vs › | $47.27M | -28.20% | -53.22% | -59.23% | -46.35% |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.65M | -57.10% | -36.66% | -227.16% | -314.45% |
| Clene Inc. (CLNN)vs › | $50.86M | N/A | 296.81% | -175.08% | -1071.79% |
ROE
-90.4%
ROA
-68.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -90.44% |
| 2026-03-31 | -211.99% |
| 2025-12-31 | -195.26% |
| 2025-09-30 | -196.58% |
| 2025-06-30 | -192.29% |
| 2025-03-31 | -137.49% |
| 2024-12-31 | -131.11% |
| 2024-09-30 | -106.71% |
| 2024-06-30 | -101.79% |
| 2024-03-31 | -118.86% |
| 2023-12-31 | -78.68% |
| 2023-09-30 | -61.33% |
| 2023-06-30 | -52.50% |
| 2023-03-31 | -48.71% |
| 2022-12-31 | -45.42% |
| 2022-09-30 | -48.88% |
| 2022-06-30 | -47.00% |
| 2022-03-31 | -43.21% |
| 2021-12-31 | -37.82% |
| 2021-09-30 | -27.05% |
| 2021-06-30 | -44.25% |
| 2021-03-31 | -22.95% |
| 2020-12-31 | -31.22% |
| 2020-09-30 | -27.21% |
| 2020-06-30 | -44.10% |
| 2020-03-31 | -35.02% |
| 2019-12-31 | -32.52% |
| 2019-09-30 | -29.30% |
| 2019-06-30 | -21.29% |
| 2019-03-31 | -50.28% |
| 2018-12-31 | -75.21% |
| 2018-09-30 | -62.91% |
| 2018-06-30 | -54.10% |
| 2018-03-31 | -20.11% |
| 2017-12-31 | -4.81% |
| 2017-09-30 | -30.82% |
